Results for:(43 found)
Sep 21, 2012 10:34AM on Top StocksBy TheStockAdvisors

The drug company is a defensive, income generator with added potential for capital gains.

Tags: AZNBMY
Sep 19, 2012 11:01AM on Top StocksBy MSN Money Partner

GlaxoSmithKline is downgraded to 'underperform,' while AstraZeneca is upgraded to 'neutral.'

Sep 10, 2012 11:18AM on Top StocksBy MSN Money Partner

Sprint is upgraded to 'buy,' and Celgene is downgraded to 'neutral.'

Aug 20, 2012 11:08AM on Top StocksBy MSN Money Partner

AstraZeneca is downgraded to 'underweight,' and Oracle is initiated with a 'buy.'

Aug 14, 2012 8:15AM on Top StocksBy Melly Alazraki

Growth reports in Germany and France come in better than forecast. Retail sales in the US increase for the first time in 4 months. Groupon shares plunge to record low on a revenue miss and lowered outlook. Home Depot climbs as it beats expectations.

Jul 16, 2012 11:41AM on Top StocksBy TheStockAdvisors

These stocks offer generous dividends while investors wait for a recovery.

Jul 6, 2012 10:50AM on Top StocksBy MSN Money Partner

Limited is initiated with a 'market perform,' and Seagate is downgraded to 'neutral.'

Jul 2, 2012 2:35PM on Top StocksBy Minyanville

The transaction also includes a $3.4 billion payment from AstraZeneca as the big drug companies try to replace lost sales from products with generic competition.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More